🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Squamous Non-Small Cell Lung Cancer sqNSCLC

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988Phase 1, Phase 214 sites📍 Los Angeles📍 Newport Beach📍 Aurora Volastra Therapeutics, Inc. · Tests: VLS-1488 Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study) NCT07744698Phase 41 site📍 Hefei Anhui Provincial Cancer Hospital · Tests: Paclitaxel Oral Solution, PD-1/PD-L1 inhibitor (eg. Tislelizumab) A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors NCT07730021Phase 1, Phase 24 sites📍 Lake Success📍 Fairfax📍 Chuo-ku Astellas Pharma Global Development, Inc. · Tests: ASP388B, Pembrolizumab, Carboplatin, Oxaliplatin, 5-fluorouracil A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) NCT05613413Phase 21 site📍 Chicago University of Illinois at Chicago · Tests: Pacliltaxel or Nab-paclitaxel, Carboplatin or Cisplatin, Pembrolizumab, Cabozantinib RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC) NCT07416474Phase 378 sites📍 Hefei📍 Beijing📍 Chongqing RemeGen Co., Ltd. · Tests: RC148 plus Carboplatin and Paclitaxel, Tislelizumab plus Carboplatin and Paclitaxel A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers NCT05910827Phase 1, Phase 220 sites📍 Sydney📍 Westmead📍 Brisbane Hummingbird Bioscience · Tests: HMBD-001, Docetaxel, Cetuximab A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors NCT07241039Phase 113 sites📍 Duarte📍 Irvine📍 Chicago AbbVie · Tests: ABBV-711, Budigalimab First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer NCT06799065Phase 1, Phase 211 sites📍 Aurora📍 Sarasota📍 Detroit Accent Therapeutics · Tests: ATX-295, ATX-295 and bevacizumab (or biosimilar)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy